Sfoglia per AUTORE
FUSCO V
Collezione ASL Biella

  

Items : 3

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria
ASL Biella

Torri V; Orecchia S; Fusco V; Traverso E; Solaini L; Ercolani G; Cavaliere D; Buccianti P; Balestri R; Ceccarelli C; Coratti A; Menegatti B; Perna F; Contardo T; Mammano E; Morpurgo E; Pulighe F; De Nisco C; Pernazza G; Ruffo G; Alongi F; Bertocchi E; Gori S; Perinotti R; Rosati R; Delpini R; Boni L; Elmore U; Baldari L; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
ASL Biella
AOU Alessandria
AOU Novara

Franzone P; Numico G; Priora F; Rossi M; Fusco V; Traverso E; Torri V; Cavaliere D; Solaini L; Ercolani G; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Menegatti B; Coratti A; Perna F; Rosati R; Delpini R; Elmore U; Mammano E; Contardo T; Morpurgo E; Perinotti R; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
ASL Biella
AOU Alessandria
AOU Novara

Orecchia S; Numico G; Franzone P; Priora F; Rossi M; Fusco V; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Buccianti P; Balestri R; Menegatti B; Gentilli S; Baroffio P; Perna F; Coratti A; Delpini R; Rosati R; Elmore U; Mammano E; Pulighe F; De Nisco C; Perinotti R; Morpurgo E; Boni L; Contardo T; et alii...